Study to Assess Cardiac Conduction of GSK1349572

NCT00996021 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

42

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Subjects

Interventions

DRUG: GSK1349572 250 mg
DRUG: Placebo Suspension
DRUG: Moxifloxacin 400 mg

Sponsor

GlaxoSmithKline

Collaborators

[object Object]